LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum lineNicoletta Colombo, Andrés Poveda, Alain G. Zeimet et al.|Annals of Oncology|2020Cited by 23
Increased peritoneal TGF-β1 is associated with ascites-induced NK-cell dysfunction and reduced survival in high-grade epithelial ovarian cancerRalph J. A. Maas, Harry Dolstra, Janneke S. Hoogstad‐van Evert et al.|Frontiers in Immunology|2024Cited by 21
Intraperitoneal infusion of stem cell-derived natural killer cells in recurrent epithelial ovarian cancer patients: Results of the phase 1 INTRO-01 trialJanneke S. Hoogstad‐van Evert, Harry Dolstra, Paul K.J.D. de Jonge et al.|Gynecologic Oncology|2025Cited by 6
Intraperitoneal Infusion of Stem Cell-Derived Natural Killer Cells in Recurrent Epithelial Ovarian Cancer Patients: Results of the Phase 1 INTRO-01 TrialJanneke Hoogstad, Harry Dolstra, Paul K.J.D. de Jonge et al.|SSRN Electronic Journal|2025Cited by 0